Georgette Plemper van Balen

Medicine · Health Sciences

12h-index1.7kcitations17works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(9), Antibiotics Pharmacokinetics and Efficacy(4), Lipid Membrane Structure and Behavior(3), Pneumonia and Respiratory Infections(3), Phenothiazines and Benzothiazines Synthesis and Activities(3)

Publications17 total

Protein binding of rifampicin is not saturated when using high-dose rifampicin
Journal of Antimicrobial Chemotherapy·2018· 19 cited
Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis
Antimicrobial Agents and Chemotherapy·2017· 90 citedOpen Access
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
The Lancet Infectious Diseases·2016· 380 citedOpen Access
A Step toward an Optimized Rifampin Dose Completed
American Journal of Respiratory and Critical Care Medicine·2015· 7 cited
A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis
American Journal of Respiratory and Critical Care Medicine·2015· 311 citedOpen Access
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
Journal of Antimicrobial Chemotherapy·2015· 91 citedOpen Access
The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially reflecting the impact of chemotherapy on critical sub-populations
Journal of Antimicrobial Chemotherapy·2014· 73 citedOpen Access
Modifying the multi-arm multi-stage (MAMS) design for use in a phase II tuberculosis trial in sub-Saharan Africa with a time-to-event primary outcome
Trials·2013Open Access
High-dose rifampicin: how do we proceed? [Correspondence]
The International Journal of Tuberculosis and Lung Disease·2011· 9 cited
Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
Clinical Infectious Diseases·2011· 238 citedOpen Access
Liposome/Water Lipophilicity: Methods, Information Content, and Pharmaceutical Applications
ChemInform·2004· 1 cited
Liposome/water lipophilicity: Methods, information content, and pharmaceutical applications
Medicinal Research Reviews·2004· 109 cited
Recognition forces involved in mitochondrial binding to a low-affinity trimetazidine binding site related to anti-ischemic activity
Biochemical Pharmacology·2002· 19 cited
Lipophilicity Behaviour of the Zwitterionic Antihistamine Cetirizine in Phosphatidylcholine Liposomes/Water Systems
Pharmaceutical Research·2001· 45 cited
Molecular-Dynamics and NMR Investigation of the Property Space of the Zwitterionic Antihistamine Cetirizine
Helvetica Chimica Acta·2001· 8 cited
Ionic Partition Diagram of the Zwitterionic Antihistamine Cetirizine
Helvetica Chimica Acta·2001· 36 citedOpen Access
Influence of iron chelation on the antioxidant activity of flavonoids
Biochemical Pharmacology·1998· 290 cited

Frequent Co-authors

Martin J. Boeree(12), Stephen H. Gillespie(10), Patrick Phillips(9), Norbert Heinrich(8), Rodney Dawson(8), Michael Höelscher(8), Rob E. Aarnoutse(7), Andreas H. Diacon(6), Sunita Rehal(6), Amour Venter(6), Kim Narunsky(6), Bernard Testa(6), Giulia Caron(5), Géraldine Bouchard(5), Pierre‐Alain Carrupt(5), Roberta Fruttero(5), Gibson Kibiki(4), Hadija Semvua(4), Stellah Mpagama(4), Bariki Mtafya(4)